Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature

Journal of Neuropathology and Experimental Neurology

Volumn 74, Issue 7, 2015, Pages 642-652

  Ighodaro, Eseosa T ^b   Jicha, Gregory A ^b   Schmitt, Frederick A ^b   Neltner, Janna H ^a   Abner, Erin L ^a,b   Kryscio, Richard J ^a,b   Smith, Charles D ^b   Duplessis, Taylor ^b   Anderson, Sonya ^b   Patel, Ela ^b   Bachstetter, Adam ^b   Van Eldik, Linda J ^b   Nelson, Peter T ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Biomarkers; Case study; Dementia; Frontotemporal lobar degeneration (FTLD); Hippocampal sclerosis; Neuropathology; Oldest old

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTERIOLOSCLEROSIS; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; DEGENERATIVE DISEASE; EPILEPSY; FRONTOTEMPORAL DEMENTIA; GLIOSIS; HEMATOXYLIN AND EOSIN STAINING; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MINI MENTAL STATE EXAMINATION; NERVE CELL LESION; NEUROIMAGING; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; TDP 43 PROTEINOPATHY; AGED; CASE REPORT; COMPLICATION; FEMALE; MALE; METABOLISM; PATHOLOGY; SCLEROSIS; VERY ELDERLY;

DNA BINDING PROTEIN; PROTEIN TDP-43;

AGED; AGED, 80 AND OVER; AGING; DNA-BINDING PROTEINS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NEURODEGENERATIVE DISEASES; SCLEROSIS;

EID: 84934292543     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000204     Document Type: Review

References (76)

1. Nelson PT, Schmitt FA, Lin Y, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011;134:1506-18
2. Pao WC, Dickson DW, Crook JE, et al. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 2011;25:364-8
3. Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol 1994;88:212-21
4. Zarow C, Sitzer TE, Chui HC. Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues. Curr Neurol Neurosci Rep 2008;8:363-70
5. Nelson PT, Smith CD, Abner EL, et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 2013;126:161-77
6. Leverenz JB, Agustin CM, Tsuang D, et al. Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 2002;59:1099-106
7. Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012;123:1-11
8. Brenowitz WD, Monsell SE, Schmitt FA, et al. Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimer's Dis 2014;39:691-702
9. Amador-Ortiz C, Dickson DW. Neuropathology of hippocampal sclerosis. Handb Clin Neurol 2008;89:569-72
10. Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007;61:435-45
11. Amador-Ortiz C, Ahmed Z, Zehr C, et al. Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol 2007;113:245-52
12. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-3
13. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-11
14. Keage HA, Hunter S, Matthews FE, et al. TDP-43 in the population: prevalence and associations with dementia and age. J Alzheimer's Disease 2014;42:641-50
15. Lee EB, Lee VM, Trojanowski JQ, et al. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol 2008;115:305-11
16. Markesbery WR, Schmitt FA, Kryscio RJ, et al. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006;63:38-46
17. Schmitt FA, Nelson PT, Abner E, et al. University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res 2012;9:724-33
18. Nelson PT, Jicha GA, Schmitt FA, et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles ''do count'' when staging disease severity. J Neuropathol Exp Neurol 2007;66:1136-46
19. Mathews M, Abner E, Caban-Holt A, et al. CERAD practice effects and attrition bias in a dementia prevention trial. Int Psychogeriatrics 2013;25:1115-23
20. Abner EL, Dennis BC, Mathews MJ, et al. Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial. Trials 2012;13:217
21. Mathews M, Abner E, Kryscio R, et al. Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery. Alzheimer's Dement 2014;10:675-83
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psych Res 1975;12:189-98
23. Nelson PT, Smith CD, Abner EA, et al. Human cerebral neuropathology of type 2 diabetes mellitus. Biochim Biophys Acta 1792;2009:454-69
24. Zarow C, Wang L, Chui HC, et al. MRI shows more severe hippocampal atrophy and shape deformation in hippocampal sclerosis than in Alzheimer's disease. Int J Alzheimer's Dis 2011;2011:483972
25. Thom M. Hippocampal sclerosis: progress since Sommer. Brain Pathol 2009;19:565-72
26. Attems J, Jellinger KA. Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology 2006;66:775
27. Kuslansky G, Verghese J, Dickson D, et al. Hippocampal sclerosis: cognitive consequences and contribution to dementia. Neurology 2004;62:A128-9
28. Zabar Y, Carson KA, Troncoso JC, et al. Dementia due to hippocampal sclerosis: clinical features and comparison to Alzheimer's disease. Neurology 1998;50:A59-60
29. Zarow C, Weiner MW, Ellis WG, et al. Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav 2012;2:435-42
30. Hatanpaa KJ, Raisanen JM, Herndon E, et al. Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields. J Neuropathol Exp Neurol 2014;73:136-42
31. Robinson JL, Geser F, Corrada MM, et al. Neocortical and hippocampal amyloid-beta and tau measures associate with dementia in the oldest-old. Brain 2011;134:3708-15
32. Nelson PT, Abner EL, Schmitt FA, et al. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol 2010;20:66-79
33. Murray ME, Cannon A, Graff-Radford NR, et al. Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol 2014;128:411-21
34. Josephs KA, Whitwell JL, Weigand SD, et al. TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol 2014;127:811-24
35. Wilson RS, Yu L, Trojanowski JQ, et al. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol 2013;70:1418-24
36. Aoki N, Murray ME, Ogaki K, et al. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol 2015;129:53-64
37. Dickson DW, Baker M, Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 2010;7:170-4
38. Probst A, Taylor KI, Tolnay M. Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 2007;114:335-45
39. Blass DM, Hatanpaa KJ, Brandt J, et al. Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology 2004;63:492-7
40. Rauramaa T, Pikkarainen M, Englund E, et al. Consensus recommendations on pathologic changes in the hippocampus: a postmortem multicenter inter-rater study. J Neuropathol Exp Neurol 2013;72:452-61
41. Hatanpaa KJ, Blass DM, Pletnikova O, et al. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 2004;63:538-42
42. Hatanpaa KJ, Bigio EH, Cairns NJ, et al. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study. J Neuropathol Exp Neurol 2008;67:271-9
43. Nelson PT, Estus S, Abner EL, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol 2014;127:825-43
44. Nelson PT, Wang WX, Partch AB, et al. Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol 2015;74:75-84
45. Nicholson AM, Finch NA, Wojtas A, et al. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia. J Neurochem 2013;126:781-91
46. Yu L, De Jager PL, Yang J, et al. The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology 2015;84:927-34
47. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54
48. Snowden JS, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012;135:693-708
49. Mendez MF, Joshi A, Tassniyom K, et al. Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology 2013;80:561-8
50. Walker AK, Daniels CM, Goldman JE, et al. Astrocytic TDP-43 pathology in Alexander disease. J Neurosci 2014;34:6448-58
51. Ling H, Holton JL, Lees AJ, et al. TDP-43 pathology is present in most post-encephalitic parkinsonism brains. Neuropathol Appl Neurobiol 2014;40:654-7
52. McKee AC, Gavett BE, Stern RA, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010;69:918-29
53. Davidson YS, Raby S, Foulds PG, et al. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 2011;122:703-13
54. Lippa CF, Rosso AL, Stutzbach LD, et al. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch Neurol 2009;66:1483-8
55. Onyike CU, Pletnikova O, Sloane KL, et al. Hippocampal sclerosis dementia: an amnesic variant of frontotemporal degeneration. Dementia Neuropsychol 2013;7:83-7
56. Schneider JA, Aggarwal NT, Barnes L, et al. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimer's Dis 2009;18:691-701
57. Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406-13
58. Tschanz JT, Treiber K, Norton MC, et al. A population study of Alzheimer's disease: findings from the Cache County Study Group. Care Manag J 2005;Summer;6:107-14
59. Giasson BI, Forman MS, Higuchi M, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003;300:636-40
60. Lippa CF, Fujiwara H, Mann DM, et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-70
61. Rosenberg CK, Pericak-Vance MA, Saunders AM, et al. Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation. Acta Neuropathol 2000;100:145-52
62. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002;16:203-12
63. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002;977:9-23
64. Schneider JA, Arvanitakis Z, Bang W, et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69:2197-204
65. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66:1837-44
66. Troncoso JC, Kawas CH, Chang CK, et al. Lack of association of the apoE4 allele with hippocampal sclerosis dementia. Neurosci Lett 1996;204:138-40
67. Uchikado H, Lin WL, DeLucia MW, et al. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 2006;65:685-97
68. Neltner JH, Abner EL, Baker S, et al. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 2014;137:255-67
69. Beecham GW, Hamilton K, Naj AC, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet 2014;10:e1004606
70. Nichols CG, Singh GK, Grange DK. KATP channels and cardiovascular disease: suddenly a syndrome. Circulation Res 2013;112:1059-72
71. Flagg TP, Enkvetchakul D, Koster JC, et al. Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 2010;90:799-829
72. Gribble FM, Reimann F. Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. J Diabetes Complications 2003;17(2 Suppl):11-5
73. Lawson K. Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Internat 2000;57:838-45
74. Josephs KA, Murray ME, Whitwell JL, et al. Staging TDP-43 pathology in Alzheimer's disease. Acta Neuropathol 2014;127:441-50
75. Knopman DS, Roberts RO. Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci 2011;45:330-5
76. Nag S, Yu L, Capuano AW, et al. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease [epub ahead of print February 23, 2015]. Ann Neurol